SPAC8C9.04 Antibody

Shipped with Ice Packs
In Stock

Description

Overview of SPAC8CAntibody

The SPAC8C9.04 Antibody (Product Code: CSB-PA515665XA01SXV) is designed to detect the SPAC8C9.04 gene product, a protein encoded by the fission yeast genome. Its UniProt accession number is O14273, though functional annotation for this protein remains limited in public databases.

Biological Context of SPAC8Cin Fission Yeast

While direct functional studies on SPAC8C9.04 are sparse, fission yeast proteins with similar nomenclature (e.g., SPAC-coded genes) are often involved in:

  • Cell cycle regulation (e.g., kinases, phosphatases) .

  • Vesicle transport (e.g., COPII components like Sec31) .

  • Stress response pathways (e.g., TOR signaling) .

Comparative Phosphoproteomics Insights:

A 2024 phosphoproteomic study identified phosphorylation sites in fission yeast proteins under nutrient stress, including SPAC-coded genes involved in actin cytoskeleton organization and translation regulation . Although SPAC8C9.04 was not explicitly highlighted, its potential role in similar pathways warrants further investigation.

A. Hypothetical Use Cases

  1. Protein Localization Studies:

    • Determine subcellular localization via immunofluorescence in fission yeast.

    • Compare expression under stress conditions (e.g., nitrogen limitation) .

  2. Interaction Networks:

    • Co-immunoprecipitation (Co-IP) to identify binding partners (e.g., kinases/phosphatases).

  3. Functional Knockdown Analysis:

    • Pair with CRISPR/Cas9 deletion strains to study phenotypic effects.

B. Technical Considerations

  • Cross-Reactivity: Antibodies targeting fission yeast proteins often require validation against S. cerevisiae homologs to rule off-target binding .

  • Epitope Stability: Fragmentation (e.g., Fab or F(ab')₂) may improve penetration in fixed samples .

Gaps and Future Directions

  1. Functional Annotation: No published studies directly link SPAC8C9.04 to specific pathways.

  2. Validation Needs:

    • Knockout strain western blots to confirm specificity.

    • Structural characterization (e.g., cryo-ET) to map epitopes .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPAC8C9.04 antibody; Meiotically up-regulated protein C8C9.04 antibody
Target Names
SPAC8C9.04
Uniprot No.

Target Background

Function
SPAC8C9.04 Antibody plays a crucial role in the processes of meiosis and sporulation.
Database Links

Q&A

What is SPAC8C9.04 and why is it significant in molecular biology research?

SPAC8C9.04 is a protein-coding gene in the fission yeast Schizosaccharomyces pombe, which has emerged as an important model organism for studying fundamental cellular processes. Recent studies have shown that SPAC8C9.04 is located within heterochromatin islands that form during epigenetic adaptations. Specifically, the gene is part of an approximately 8 kb heterochromatin region in the UR3 epimutant strain, alongside other genes including Cgs1, Dtd1, Ppr4, Fyv7, and Rps5 .

The significance of SPAC8C9.04 lies in its potential role in heterochromatin formation and maintenance. Heterochromatin research is critical for understanding epigenetic regulation, with implications for gene silencing, genome stability, and cellular adaptation to stress. Antibodies against SPAC8C9.04 provide researchers with tools to:

  • Track protein localization during cell cycle phases

  • Determine protein expression levels in response to environmental stressors

  • Identify interaction partners in various cellular pathways

  • Investigate its potential role in rapid epigenetic adaptation mechanisms

How should researchers validate the specificity of SPAC8C9.04 antibody?

Validating antibody specificity is crucial for reliable experimental results. For SPAC8C9.04 antibody, researchers should employ multiple validation strategies:

Recommended Validation Protocol:

  • Western Blot Analysis with Controls:

    • Wild-type S. pombe lysate (positive control)

    • SPAC8C9.04 deletion strain lysate (negative control)

    • Competing peptide blocking experiment

  • Immunoprecipitation Followed by Mass Spectrometry:

    • This approach can confirm that the antibody pulls down the intended protein target

    • Similar to techniques described for antibody identification via cryoEM

  • Epitope Mapping:

    • Determine the specific binding region using peptide arrays

    • Compare with known protein domains and structures

  • Immunofluorescence Correlation:

    • Compare antibody staining patterns with GFP-tagged SPAC8C9.04

Validation MethodExpected ResultPotential IssuesResolution
Western BlotSingle band at predicted MWMultiple bandsOptimize antibody concentration (0.1-1 μg/mL)
Knockout ControlNo band in deletion strainPersistent bandConsider antibody cross-reactivity
Mass Spec ValidationSPAC8C9.04 as top hitLow peptide coverageIncrease input material
ImmunofluorescencePattern matching GFP fusionNon-specific stainingOptimize fixation methods

What are the optimal conditions for using SPAC8C9.04 antibody in immunoblotting experiments?

Optimizing conditions for immunoblotting with SPAC8C9.04 antibody requires systematic testing of several parameters:

Recommended Protocol:

  • Sample Preparation:

    • Lyse cells in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, with protease inhibitors

    • Include phosphatase inhibitors if studying post-translational modifications

  • Antibody Dilution:

    • Start with a titration series (1:500 to 1:5000)

    • Recent studies on antibody optimization suggest that concentrations can often be drastically reduced without loss of signal specificity

  • Blocking and Incubation:

    • 5% non-fat dry milk or BSA in TBST (Tris-buffered saline with 0.1% Tween-20)

    • Incubate primary antibody at 4°C overnight with gentle agitation

    • Secondary antibody incubation: 1 hour at room temperature

  • Detection Method:

    • For low abundance proteins, enhanced chemiluminescence (ECL) or fluorescent secondary antibodies are recommended

Optimization Table:

ParameterStarting ConditionOptimization RangeNotes
Antibody Concentration1:10001:500 - 1:5000Titrate to minimize background
Blocking Agent5% Milk in TBST1-5% Milk or BSABSA may be better for phospho-epitopes
Incubation TimeOvernight at 4°C1h at RT to overnight at 4°CLonger incubation may improve sensitivity
Washing Steps3 × 10 min TBST3-5 × 5-15 minThorough washing reduces background

How can SPAC8C9.04 antibody be effectively used in chromatin immunoprecipitation (ChIP) experiments?

ChIP experiments with SPAC8C9.04 antibody can reveal genome-wide binding patterns and help understand its potential role in heterochromatin formation:

ChIP Protocol Optimization:

  • Crosslinking Conditions:

    • 1% formaldehyde for 10 minutes at room temperature

    • For proteins with weak DNA interactions, consider using dual crosslinkers (formaldehyde plus DSG or EGS)

  • Chromatin Shearing:

    • Target fragment size: 200-500 bp

    • Optimization of sonication conditions is critical for S. pombe due to its cell wall

  • Immunoprecipitation:

    • Pre-clear lysates with Protein A/G beads

    • Use 2-5 μg antibody per ChIP reaction

    • Include appropriate controls (IgG, input, and if possible, a strain lacking SPAC8C9.04)

  • Washing and Elution:

    • Stringent washing steps to reduce background

    • Elution with SDS-containing buffer followed by crosslink reversal

  • Analysis Methods:

    • qPCR for targeted regions

    • ChIP-seq for genome-wide binding profiles

Research on heterochromatin formation in S. pombe has shown that appropriate ChIP conditions are critical for detecting proteins involved in epigenetic regulation . Given that SPAC8C9.04 may be involved in heterochromatin islands, optimizing antibody concentration and washing conditions is particularly important.

What strategies can researchers employ to minimize background and non-specific binding when using SPAC8C9.04 antibody?

Reducing background is crucial for obtaining clear and interpretable results, especially when studying proteins that may be expressed at relatively low levels:

Background Reduction Strategies:

  • Antibody Titration:

    • According to recent research on oligo-conjugated antibodies, using substantially lower concentrations than manufacturer recommendations can dramatically reduce background while maintaining specific signal

    • For SPAC8C9.04 antibody, a titration from 0.1 μg/mL to 5 μg/mL is recommended

  • Blocking Optimization:

    • Test different blocking agents (BSA, casein, non-fat dry milk)

    • Include 0.1-0.5% detergent (Tween-20, Triton X-100) in washing buffers

  • Pre-absorption:

    • Incubate antibody with lysates from SPAC8C9.04 deletion strains to remove cross-reactive antibodies

    • Use peptide competition assays to determine specificity

  • Cell Fixation and Permeabilization (for Immunofluorescence):

    • Test different fixatives (paraformaldehyde, methanol, acetone)

    • Optimize permeabilization conditions to balance antigen accessibility with structural preservation

MethodImplementationExpected Outcome
Antibody DilutionSerial dilutions (1:500 to 1:5000)Determine optimal concentration with highest signal-to-noise ratio
Pre-absorptionIncubate with null mutant extractRemoves antibodies that bind to proteins other than target
Stringent WashingIncrease salt concentration to 300-500 mMReduces non-specific electrostatic interactions
Detergent OptimizationTest 0.1%, 0.3%, and 0.5% Tween-20Minimizes hydrophobic non-specific interactions

How can SPAC8C9.04 antibody be used to study heterochromatin dynamics in fission yeast?

Understanding heterochromatin formation and maintenance is a key area of epigenetic research, and SPAC8C9.04 has been identified in heterochromatin islands :

Experimental Approaches:

  • ChIP-seq Time Course Studies:

    • Track SPAC8C9.04 association with chromatin during cell cycle progression

    • Compare binding patterns in wild-type versus epigenetic mutants (e.g., clr4Δ, swi6Δ)

    • Analyze heterochromatin spreading in conditions where anti-silencing factors are compromised

  • Co-immunoprecipitation with Heterochromatin Factors:

    • Use SPAC8C9.04 antibody to pull down associated proteins

    • Identify interactions with known heterochromatin components (Clr4, Swi6)

    • Apply mass spectrometry to discover novel interaction partners

  • Chromatin Spreading Assays:

    • Track heterochromatin formation in mst2Δ epe1Δ backgrounds, which show uncontrolled heterochromatin spreading

    • Determine if SPAC8C9.04 is affected by or contributes to heterochromatin formation

  • Immunofluorescence Combined with FISH:

    • Visualize co-localization of SPAC8C9.04 with heterochromatin markers

    • Track relocalization during epigenetic adaptation processes

Research has shown that fission yeast can quickly adapt to heterochromatin stress through epigenetic mutations . SPAC8C9.04 antibody could be instrumental in understanding whether this protein plays a role in such adaptations.

What considerations should be made when designing immunoprecipitation experiments with SPAC8C9.04 antibody?

Immunoprecipitation (IP) is a powerful technique for studying protein-protein interactions and post-translational modifications:

IP Protocol Recommendations:

  • Lysis Conditions:

    • Use gentle lysis buffers to preserve protein-protein interactions

    • Standard buffer: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% NP-40, with protease and phosphatase inhibitors

  • Antibody Coupling Strategies:

    • Direct addition of antibody to lysate followed by Protein A/G beads

    • Pre-coupling antibody to beads to reduce background from antibody heavy and light chains

    • Consider covalent cross-linking of antibody to beads for cleaner results

  • Controls and Validation:

    • Include IgG control IP

    • Validate interactions by reciprocal IP when possible

    • Consider using tagged versions of SPAC8C9.04 as additional controls

  • Elution Methods:

    • Mild: Competition with excess antigen peptide

    • Standard: SDS sample buffer (disrupts most interactions)

    • For subsequent functional assays: Elution with excess antigenic peptide

Troubleshooting Guide:

IssuePossible CauseSolution
No IP of target proteinEpitope masked in native conditionsTry different lysis buffers or denaturing conditions
High backgroundInsufficient washingIncrease wash stringency; use detergent gradient
Loss of interacting partnersWash conditions too stringentReduce salt concentration; use gentler detergents
Inconsistent resultsVariability in antibody-bead couplingUse pre-coupled or cross-linked antibody-bead complexes

How can researchers use SPAC8C9.04 antibody in conjunction with mass spectrometry for interaction studies?

Combining immunoprecipitation with mass spectrometry (IP-MS) offers powerful insights into protein interaction networks:

IP-MS Workflow:

  • Sample Preparation:

    • Perform IP as described above

    • Include appropriate controls (IgG IP, lysate from deletion strain)

    • Consider SILAC or TMT labeling for quantitative comparisons

  • On-Bead Digestion:

    • Wash immunoprecipitated complexes extensively

    • Perform tryptic digestion directly on beads

    • Extract peptides for MS analysis

  • Mass Spectrometry Analysis:

    • Use high-resolution MS for accurate protein identification

    • Implement strategies similar to those described for antibody-antigen complex identification

  • Data Analysis:

    • Filter against control IP datasets

    • Use statistical tools to identify significant interactors

    • Validate key interactions by orthogonal methods

Recent advances in structural and functional evaluation of antibody-antigen complexes using cryoEM can be adapted to study SPAC8C9.04 interactions, providing insights not only into binding partners but also into the structural basis of these interactions .

What are the considerations when using SPAC8C9.04 antibody for studying mitochondrial function in fission yeast?

Recent research suggests links between heterochromatin formation and mitochondrial function in fission yeast . Since SPAC8C9.04 is within heterochromatin islands that form during epigenetic adaptations, studying its potential relationship with mitochondrial function requires specific considerations:

Experimental Design:

  • Subcellular Fractionation:

    • Separate mitochondrial, nuclear, and cytosolic fractions

    • Use SPAC8C9.04 antibody to track protein localization across fractions

    • Include markers for each compartment as controls

  • Co-localization Studies:

    • Combine SPAC8C9.04 antibody with mitochondrial markers

    • Use super-resolution microscopy for detailed localization analysis

  • Functional Assays:

    • Compare mitochondrial function in wild-type versus SPAC8C9.04 mutant strains

    • Measure ROS levels, respiration rates, and mitochondrial membrane potential

    • Assess activation of the mito-nuclear retrograde (MNR) response pathway

  • Gene Expression Analysis:

    • Correlate SPAC8C9.04 protein levels with expression of mitochondrial genes

    • Investigate relationships with oxidative stress response genes

The data from search result indicates that heterochromatin formation affecting genes like SPAC8C9.04 can influence mitochondrial function and stress responses in fission yeast. This presents an intriguing area for investigation using SPAC8C9.04 antibody.

How can SPAC8C9.04 antibody be adapted for multiplexed imaging techniques?

Advanced imaging techniques enable visualization of multiple proteins simultaneously, providing insights into complex cellular processes:

Multiplexing Strategies:

  • Antibody Labeling Options:

    • Direct fluorophore conjugation

    • Secondary antibody with distinct fluorophores

    • Using oligo-conjugated antibodies for CODEX or similar technologies

  • Multicolor Immunofluorescence:

    • Combine SPAC8C9.04 antibody with antibodies against heterochromatin markers (H3K9me, Swi6)

    • Use spectrally distinct fluorophores

    • Include appropriate controls for cross-reactivity

  • Sequential Imaging:

    • Apply SPAC8C9.04 antibody, image, then strip and reprobe

    • Preserve sample integrity between cycles

    • Use registration markers for image alignment

  • Advanced Technologies:

    • Consider adapting techniques similar to the oligo-conjugated antibody approach described in result

    • Optimization of antibody concentration is crucial for reducing background in multiplexed imaging

Multiplexing MethodAdvantagesConsiderations
Traditional Multicolor IFSimple implementationLimited by spectral overlap (3-5 colors)
Sequential ImagingUnlimited targetsTime-consuming; potential sample deterioration
Mass Cytometry (CyTOF)40+ parametersSpecialized equipment; no morphological data
Oligo-Conjugated AbsHigh parameter; spatial infoRequires optimization of oligo density and antibody concentration

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.